Literature DB >> 31131663

Optical Coherence Tomography Angiography: Review of Current Technical Aspects and Applications in Chorioretinal Disease.

Jay C Wang1, John B Miller1.   

Abstract

Optical coherence tomography angiography (OCT-A) has enabled fast, non-invasive, high-resolution visualization of vasculature within the eye. In the past few years, it has become increasingly utilized for a range of disorders including age-related macular degeneration, diabetic retinopathy, retinal vein occlusions, and uveitis among others. This article reviews technical aspects of OCT-A, its applications in chorioretinal disease, and known limitations of the technology.

Entities:  

Keywords:  Imaging; optical coherence tomography; optical coherence tomography angiography; retina; review

Mesh：

Year:  2019        PMID： 31131663     DOI： 10.1080/08820538.2019.1620797

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN： 0882-0538            Impact factor:   1.975


  3 in total

1.  Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients.

Authors:  Bettina Hohberger; Sami Hosari; Gerd Wallukat; Rudolf Kunze; Johann Krebs; Meike Müller; Till Hennig; Robert Lämmer; Folkert Horn; Luis E Muñoz; Martin Herrmann; Christian Mardin
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

2.  Characterizing Flow and Structure of Diabetic Retinal Neovascularization after Intravitreal Anti-VEGF Using Optical Coherence Tomography Angiography: A Pilot Study.

Authors:  Christof Haensli; Katrin Fasler; Daniel Barthelmes; Sandrine A Zweifel
Journal:  J Ophthalmol       Date:  2021-07-14       Impact factor: 1.909

3.  Multicontrast investigation of in vivo wildtype zebrafish in three development stages using polarization-sensitive optical coherence tomography.

Authors:  Antonia Lichtenegger; Pradipta Mukherjee; Junya Tamaoki; Lixuan Bian; Lida Zhu; Ibrahim Abd El-Sadek; Shuichi Makita; Konrad Leskovar; Makoto Kobayashi; Bernhard Baumann; Yoshiaki Yasuno
Journal:  J Biomed Opt       Date:  2022-01       Impact factor: 3.758
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.